(Q40665794)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

title

Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Aliana Guerrieri Gonzaga

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

11

Viviana Galimberti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

5

Nicole Rotmensz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

10

Roberto Orecchia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Ivana Sestak

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Davide Serrano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Massimiliano Cazzaniga

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Clara Varricchio

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Giancarlo Pruneri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Maria Cristina Leonardi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Bernardo Bonanni

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Andrea DeCensi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

language of work or name

English

0 references

publication date

19 July 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

17 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

2127-2134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

Selecting individualized treatment for patients with ductal carcinoma in situ of the breast: the search continues

17 March 2020

cites work

1 reference

National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.

21 January 2018

1 reference

Recent advances and current controversies in the management of DCIS of the breast

21 January 2018

1 reference

Addressing overtreatment of screen detected DCIS; the LORIS trial

21 January 2018

1 reference

Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ

21 January 2018

1 reference

Post-operative radiotherapy for ductal carcinoma in situ of the breast

21 January 2018

1 reference

Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype

21 January 2018

1 reference

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

21 January 2018

1 reference

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

21 January 2018

1 reference

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation

21 January 2018

1 reference

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

21 January 2018

1 reference

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

Risk of ischemic heart disease in women after radiotherapy for breast cancer

21 January 2018

1 reference

Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients

21 January 2018

1 reference

A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers

21 January 2018

1 reference

Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users.

21 January 2018

1 reference

A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study

21 January 2018

1 reference

Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience

21 January 2018

1 reference

Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasia

21 January 2018

1 reference

Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.

21 January 2018

1 reference

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

21 January 2018

1 reference

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial

21 January 2018

1 reference

Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide.

21 January 2018

1 reference

Ductal carcinoma in situ: role of the boost

21 January 2018

1 reference

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

21 January 2018

1 reference

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ

21 January 2018

1 reference

Biology, treatment, and outcome in very young and older women with DCIS.

21 January 2018

1 reference

Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ.

21 January 2018

1 reference

Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients.

21 January 2018

1 reference

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis

21 January 2018

1 reference

The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.

21 January 2018

1 reference

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ

21 January 2018

1 reference

Lifestyle factors and the risk of a second breast cancer after ductal carcinoma in situ

21 January 2018

1 reference

Obesity and the risk for premenopausal and postmenopausal breast cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.30254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381855%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference